Welcome: Zhejiang Jiachuang Medical Technology Co., Ltd
Language: Chinese ∷  English


Breast hyperplasia

Breast hyperplasia, also known as mammary gland disease, fibrocystic breast disease, or fibrocystic changes in the breast, is a benign disease that originates from abnormal breast development and degeneration. This disease is mainly related to endocrine dysfunction, including imbalanced estrogen and progesterone ratios, abnormal quality and quantity of breast sex hormone receptors, elevated prolactin levels, which may be influenced by factors such as age, menstrual history, pregnancy history, and lactation history. It is more common in women aged 30-50, and 70% to 80% of women will have varying degrees of breast hyperplasia.
The main symptoms of breast hyperplasia include breast pain, nodules or lumps, and some patients may experience nipple discharge. Patients may also experience symptoms such as anxiety, depression, and menstrual disorders. When patients experience these symptoms, they should seek medical attention promptly.
The treatment of breast hyperplasia mainly depends on the severity of symptoms, clinical manifestations, and pathological types. Patients with mild to moderate pain mainly receive psychological counseling and lifestyle adjustment. Those with persistent and severe pain can receive medication treatment, but patients should be careful not to use it for a long time to prevent adverse effects on the endometrium and ovaries. For patients with breast hyperplasia lesions, surgical treatment is not the fundamental solution to the problem. Some medications or traditional Chinese medicine treatments can also assist in relieving symptoms.
The prognosis of breast hyperplasia is usually good, and most patients have no risk of transforming into breast cancer. Atypical ductal hyperplasia and peripheral intraductal papilloma (intraductal papillomatosis) are regarded as precancerous lesions of breast cancer. Therefore, when patients are accompanied by atypical hyperplasia, it should become the focus of clinical prevention of early cancer. This disease generally does not have a significant impact on health, but some patients with severe symptoms may be affected by their quality of life.
Zhejiang Jiachuang Medical Technology Co., Ltd. is based on the concept of caring, perfect healing, and technological innovation. Together with design and production personnel with years of experience in wearable device manufacturing and research and development, we jointly develop the production of medical devices (breast pressure bandages, pressure bandages, and head bandages). “sur-trau  ® The series of products incorporates the advantages of similar domestic and foreign products, integrates, innovates, and develops several auxiliary therapeutic bandages. It was approved and filed as a Class I medical device product by the National Food and Drug Administration on March 22, 2019; The processing method, weaving process, raw material configuration, and fabric style of bandage fabrics are specifically developed for use in medical bandage products. The advantages of using this type of knitted fabric in medical bandages are clearly explained: the tension is suitable for human functionality, reduces pain, and has a short postoperative healing cycle.
Our service tenet: "Caring for postoperative health, reducing postoperative pain, and achieving scientific healing!"
Category: Breast pressure bandages, minimally invasive breast surgery pressure bandages, breast reconstruction pressure bras, breast reconstruction pressure bandages, breast shaping pressure bandages, breast augmentation pressure bras, thyroid pressure bandages, chest and abdominal pressure bandages, hernia pressure bandages, and post thoracotomy pressure bandages.


Contact: xuefeng.liu

Phone: 13634007889

Tel: 13634007889

Email: surtrau@126.com

Add: No.1 Power Plant Road, Jinmen village, Zhapu Town, Pinghu City, Zhejiang Province